🔎 Trials Near Me

Beranda › Leukemia Biphenotypic Akut › Oregon › Portland

Uji klinis Leukemia Biphenotypic Akut di Portland, OR

6 studi untuk Leukemia Biphenotypic Akut mencari peserta di lokasi sekitar Portland (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

Menerima pesertaFase 1/2
  • Oregon Health & Science University, Portland
30 Days · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT04065399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Menerima pesertaFase 3
  • Legacy Emanuel Children's Hospital, Portland
  • Oregon Health and Science University, Portland
365 Days – 25 Years · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT03959085

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Menerima pesertaFase 1/2
  • Legacy Emanuel Children's Hospital, Portland
  • Oregon Health and Science University, Portland
Hingga usia 22 · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT04726241

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Menerima pesertaFase 1/2
  • Oregon Health & Science University, Portland
Usia 13 hingga 90 · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT06533579

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Menerima pesertaFase 2
  • Oregon Health and Science University, Portland
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Jul 2026 · NCT07216443

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Menerima pesertaFase 1
  • Oregon Health & Science University, Portland
Usia 1 hingga 21 · Semua jenis kelamin · Diperbarui 6 Des 2024 · NCT05476770

Uji klinis Leukemia Biphenotypic Akut di kota lain

Studi lain di Portland

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.